Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

[II. Immunomodulation for multiple myeloma].

Ishida T.

Gan To Kagaku Ryoho. 2013 May;40(5):589-93. Japanese. No abstract available.

PMID:
23957066
2.

Novel immunomodulatory therapies in the treatment of multiple myeloma.

Anderson KC; Multiple Myeloma Research Foundation.

Oncology (Williston Park). 2004 Jul;18(8):988-90. No abstract available.

PMID:
15328893
3.

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.

Hus M, Grzasko N, Szostek M, Pluta A, Helbig G, Woszczyk D, Adamczyk-Cioch M, Jawniak D, Legiec W, Morawska M, Kozinska J, Waciński P, Dmoszynska A.

Ann Hematol. 2011 Oct;90(10):1161-6. doi: 10.1007/s00277-011-1276-2. Epub 2011 Jun 23.

4.

Novel agents to improve outcome of allogeneic transplantation for patients with multiple myeloma.

Kortüm M, Knop S, Einsele H.

Future Oncol. 2011 Jan;7(1):135-43. doi: 10.2217/fon.10.162. Review.

PMID:
21174544
5.

Thalidomide and CC-5013 in multiple myeloma: the University of Arkansas experience.

Barlogie B.

Semin Hematol. 2003 Oct;40(4 Suppl 4):33-8. Review.

PMID:
15015894
6.

[Treatment of myeloma in the elderly].

Garderet L, Isnard F, Gorin NC.

Bull Cancer. 2008 May 28;95 FMC Onco:F84-8. doi: 10.1684/bdc.2007.0548. French.

PMID:
18511373
7.

The role of immunomodulatory drugs in multiple myeloma.

Anderson KC.

Semin Hematol. 2003 Oct;40(4 Suppl 4):23-32. Review.

PMID:
15015893
8.

[Treatment of multiple myeloma].

Harousseau JL.

Schweiz Med Wochenschr. 2000 Nov 4;130(44):1649-55. Review. French.

PMID:
11103435
9.

[Treatment of multiple myeloma by immunomodulatory drugs].

Hata H.

Rinsho Ketsueki. 2011 Oct;52(10):1485-95. Review. Japanese. No abstract available.

PMID:
21971225
10.

New treatments in multiple myeloma: beyond optimal treatment.

Harousseau JL.

Ann Oncol. 2008 Jul;19 Suppl 5:v68-70. doi: 10.1093/annonc/mdn314. No abstract available.

11.

Multiple myeloma and immunomodulation: regulating the regulatory cells.

Kasyapa CS, Sher T, Chanan-Khan AA.

Leuk Lymphoma. 2012 Jul;53(7):1253-4. doi: 10.3109/10428194.2012.670233. Epub 2012 Apr 3. No abstract available.

PMID:
22397723
12.

From the guest editor: the evolving treatment paradigm in multiple myeloma.

Anderson KC.

Cancer J. 2009 Nov-Dec;15(6):456. doi: 10.1097/PPO.0b013e3181c64fae. No abstract available.

PMID:
20010163
13.

Thalidomide and lenalidomide in multiple myeloma.

Mazumder A, Jagannath S.

Best Pract Res Clin Haematol. 2006;19(4):769-80. Review.

PMID:
16997182
14.

Thalidomide responsive chronic pulmonary GVHD.

Forsyth CJ, Cremer PD, Torzillo P, Iland HJ, Young GA.

Bone Marrow Transplant. 1996 Feb;17(2):291-3.

PMID:
8640183
15.

New drugs in multiple myeloma and the significance of autologous stem cell transplants.

Jagannath S.

Clin Adv Hematol Oncol. 2009 Mar;7(3):178-9. No abstract available.

PMID:
19398940
16.

Anatomy of a successful practice-changing study: a Blood and Marrow Transplantation Clinical Trials Network-National Cancer Institute Cooperative Group collaboration.

Giralt S, McCarthy PL, Anderson KC, Carter SL, Richardson PG, Rajkumar SV, Laport GG, Stadtmauer EA, Pasquini MC, Horowitz MM.

Biol Blood Marrow Transplant. 2013 Jun;19(6):858-9. doi: 10.1016/j.bbmt.2013.03.015. Epub 2013 Mar 29. No abstract available.

17.

Maintenance treatment in multiple myeloma.

Harousseau JL.

Ann Oncol. 2008 Jun;19 Suppl 4:iv54-5. doi: 10.1093/annonc/mdn197. Review. No abstract available.

18.

[Lenalidomide. Treatment of multiple myeloma].

Musch A.

Med Monatsschr Pharm. 2008 Jan;31(1):4-8; quiz 9-10. Review. German. No abstract available. Erratum in: Med Monatsschr Pharm. 2008 Mar;31(3):106.

PMID:
18522014
19.

Treatment of newly diagnosed multiple myeloma.

Palumbo A, Magarotto V, Larocca A, Bringhen S, Falco P, Di Raimondo F, Baldini L, Boccadoro M.

Curr Hematol Malig Rep. 2008 Apr;3(2):107-14. doi: 10.1007/s11899-008-0016-8.

PMID:
20425454
20.

Thalidomide is effective for extramedullary relapse of multiple myeloma post-allogeneic bone marrow transplantation.

Biagi JJ, Prince HM.

Br J Haematol. 2001 Nov;115(2):484-5. No abstract available.

PMID:
11703354
Items per page

Supplemental Content

Write to the Help Desk